Illumina wins dismissal of US antitrust claims over DNA sequencers
MLex Summary: Illumina's motion to dismiss US claims that it illegally monopolized the market for DNA sequencing instruments has been granted by a California federal judge. US District Judge Noël Wise...To view the full article, register now.
Already a subscriber? Click here to view full article